Prahem Laboratories LLP

500mg Methylprednisolone Sodium Succinate Injection is a corticosteroid used to treat severe inflammation, allergic reactions, and autoimmune conditions.
It works by suppressing the immune response and reducing inflammation, providing rapid relief in critical conditions.

Product Name: Enzalutamide Tablets
Strength: 160 mg
Form: Tablet
Packaging: Strip 
Usage/Application: Hospital / Clinical / Prescription Use Only

Enzalutamide 160 mg is an oral androgen receptor inhibitor used in the treatment of advanced prostate cancer. It works by blocking the effect of androgens (male hormones) that promote the growth of prostate cancer cells.

Relugolix 120 mg Tablets are oral gonadotropin-releasing hormone (GnRH) receptor antagonists used in the management of advanced prostate cancer. Relugolix works by rapidly reducing testosterone levels, helping slow the progression of hormone-sensitive tumors.

It is taken once daily under medical supervision and offers a non-injectable alternative to traditional androgen-deprivation therapy. The therapy helps manage cancer growth, symptoms, and disease complications.

Ribociclib 200 mg Film-Coated Tablets are CDK4/6 inhibitors prescribed along with hormonal therapy for treating hormone receptor-positive, HER2-negative metastatic breast cancer. The medicine helps slow cancer cell division and improves survival outcomes.
This hospital-use formulation ensures controlled dispensing and is used strictly under oncologist supervision.

Fludarabine Phosphate Injection USP 50 mg is an antineoplastic (anticancer) medication used in chemotherapy. It is primarily indicated for the treatment of B-cell chronic lymphocytic leukemia (CLL) and is also used in combination therapy for certain hematologic malignancies.

This medication works by inhibiting DNA synthesis, thereby slowing or stopping the growth of cancer cells

Cetuximab 100 mg Injection is a monoclonal antibody targeting the epidermal growth factor receptor (EGFR). It helps block cancer cell growth and spread. It is used in combination with chemotherapy or radiation in colorectal and head & neck cancers.

Administered intravenously, this targeted therapy is given under strict medical monitoring and supports improved treatment outcomes in EGFR-positive patients.

Paclitaxel Protein Bound Particles Injectable 100 mg (5 ml) is an advanced chemotherapy formulation used in the treatment of breast cancer, lung cancer, and pancreatic cancer. This nanoparticle-bound form of Paclitaxel allows better delivery of the drug to tumor cells and reduces the need for solvents, making it more tolerable. It works by inhibiting cancer cell division and slowing tumor growth. Administered intravenously under strict medical supervision in a clinical setting.

Filgrastim 300 mcg Injection is a granulocyte-colony stimulating factor (G-CSF) that helps boost neutrophil production in the bone marrow. It is commonly used in patients receiving chemotherapy to reduce the risk of infections caused by low white blood cell counts (neutropenia).

It promotes quick recovery of immune function and is administered subcutaneously or intravenously under medical guidance.

Paclitaxel 300mg Injection is an antineoplastic formulation belonging to the taxane class of chemotherapy agents. It works by stabilizing microtubules and inhibiting cell division, effectively stopping the growth and spread of cancer cells. This medication is widely used in the treatment of breast, ovarian, and non-small cell lung cancers, as well as AIDS-related Kaposi’s sarcoma.

The 50 ml vial contains a concentrated sterile solution that must be diluted before intravenous administration. It is typically used in hospital and oncology centers under strict medical supervision, with dosage adjusted based on body surface area and treatment protocol. The formulation ensures consistent efficacy and is an essential component of many chemotherapy regimens.

Tolaz LA (Olanzapine Pamoate) 300 mg Prolonged Suspension for IM Injection is a long-acting antipsychotic formulation designed for the maintenance treatment of schizophrenia. This intramuscular injection provides sustained release of olanzapine, helping ensure consistent therapeutic levels and improved symptom control over an extended period.

It aids in managing hallucinations, delusions, disorganized thinking, mood disturbances, and other symptoms associated with schizophrenia. The prolonged-release formulation is especially beneficial for patients requiring reliable adherence and stable long-term treatment.